Comment on the use of the cre/loxP recombinase system for gene therapy vectors
- PMID: 11083480
- DOI: 10.1038/sj.gt.3301305
Comment on the use of the cre/loxP recombinase system for gene therapy vectors
Comment on
-
Development of synthetic promoters for radiation-mediated gene therapy.Gene Ther. 2000 Mar;7(6):511-7. doi: 10.1038/sj.gt.3301116. Gene Ther. 2000. PMID: 10757025
-
Radiation to control gene expression.Gene Ther. 2000 Jul;7(13):1085-6. doi: 10.1038/sj.gt.3301233. Gene Ther. 2000. PMID: 10918473 No abstract available.
-
A radiation-controlled molecular switch for use in gene therapy of cancer.Gene Ther. 2000 Jul;7(13):1121-5. doi: 10.1038/sj.gt.3301223. Gene Ther. 2000. PMID: 10918478
Similar articles
-
Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.Cancer Res. 2001 Aug 15;61(16):6158-62. Cancer Res. 2001. PMID: 11507067
-
Cre-loxP adenovirus-mediated foreign gene expression in skin-equivalent keratinocytes.Br J Dermatol. 2005 Jun;152(6):1391-2. doi: 10.1111/j.1365-2133.2005.06637.x. Br J Dermatol. 2005. PMID: 15949030 No abstract available.
-
New vectors for gene therapy.Stem Cells. 1998;16 Suppl 1:235-43. doi: 10.1002/stem.5530160828. Stem Cells. 1998. PMID: 11012167
-
[Progress in the study of the structure and function of Cre recombinase].Sheng Wu Gong Cheng Xue Bao. 2002 Sep;18(5):531-5. Sheng Wu Gong Cheng Xue Bao. 2002. PMID: 12561193 Review. Chinese.
-
[Gene therapy for cancer].Hokkaido Igaku Zasshi. 2000 Jul;75(4):229-35. Hokkaido Igaku Zasshi. 2000. PMID: 10976402 Review. Japanese. No abstract available.
Cited by
-
Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.Pharm Res. 2006 Jun;23(6):1053-74. doi: 10.1007/s11095-006-0164-2. Epub 2006 May 26. Pharm Res. 2006. PMID: 16715361 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical